AAAAAA
Results: 1-25/31
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
Authors:
Rascol, O
Arnulf, I
Paul, HPS
Brefel-Courbon, C
Vidailhet, M
Thalamas, C
Bonnet, AM
Descombes, S
Bejjani, B
Fabre, N
Montastruc, JL
Agid, Y
Citation: O. Rascol et al., Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease, MOVEMENT D, 16(4), 2001, pp. 708-713
Authors:
Perret, J
Bourrin, JC
Chedru, F
Carpentier, F
Davous, P
Hinault, P
Warter, JM
Boisson, D
Solignac, M
David, JP
Dien, J
Dupuy, D
Emile, J
Fischer, G
Galletti, P
Honorat, A
Kopp, M
Le Guyader, J
Maupetit, J
Oriol, JM
Deseilligny, CP
Prince, P
Benabid, A
Bleton, JP
Blond, S
Bonnet, AM
Broussolle, P
Cesaro, P
Chaperon, J
Damier, P
Defer, G
Destee, A
Fenelon, G
N'guyen, JP
Pelissier, J
Pollak, P
Rascol, O
Tison, F
Tranchant, C
Viallet, F
Vidailhet, M
Ziegler, M
Marion, MH
Brefel-Courbon, C
Derkinderen, P
Gayraud, D
Krystowiak, P
Simon, O
Thobois, S
Vercueil, L
Citation: J. Perret et al., Parkinson's disease: Diagnostic and therapeutic criteria, PRESSE MED, 30(8), 2001, pp. 379-385
Authors:
Obeso, JA
Guridi, J
Rodriguez-Oroz, MC
Agid, Y
Bejjani, P
Bonnet, AM
Lang, AE
Lozano, AM
Kumar, R
Benabid, A
Pollack, P
Krack, P
Rehncrona, S
Ekberg, R
Grabowski, M
Albanese, A
Scerrati, M
Moro, E
Koller, W
Wilkinson, SB
Pahwa, R
Volkmann, J
Allert, N
Freund, HJ
Kulisevsky, J
Gironell, A
Molet, J
Tronnier, V
Fogel, W
Krause, M
Funk, T
Kern, C
Kestenbach, U
Iansek, R
Rosenfeld, J
Churchyard, A
O'Sullivan, D
Pell, M
Markus, R
Bayes, A
Blesa, R
Oliver, B
Olanow, CW
Germano, IM
Brin, M
Jankovic, J
Grossman, RG
Ondo, WG
Vitek, JL
Bakay, RAE
DeLong, MR
Tolosa, E
Rumia, J
Valldeoriola, F
Benabid, A
Albanese, A
DeLong, MR
Lang, AM
Lozano, A
Obeso, JA
Olanow, CW
Pollack, P
Koller, WC
Vitek, J
Wilkinson, S
Citation: Ja. Obeso et al., Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease., N ENG J MED, 345(13), 2001, pp. 956-963
Authors:
Arnulf, I
Bonnet, AM
Damier, P
Bejjani, BP
Seilhean, D
Derenne, JP
Agid, Y
Citation: I. Arnulf et al., Hallucinations, REM sleep, and Parkinson's disease: A medical hypothesis -Reply from the authors, NEUROLOGY, 57(7), 2001, pp. 1351-1351
Authors:
Houeto, JL
Bonnet, AM
Pidoux, B
Dormont, D
Cornu, P
Agid, Y
Bejjani, BP
Damier, P
Citation: Jl. Houeto et al., Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD - Reply, NEUROLOGY, 57(3), 2001, pp. 566-567
Authors:
Descombes, S
Bonnet, AM
Gasser, UE
Thalamas, C
Dingemanse, J
Arnulf, I
Bareille, MP
Agid, Y
Rascol, O
Citation: S. Descombes et al., Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease, NEUROLOGY, 56(9), 2001, pp. 1239-1242
Authors:
Arnulf, I
Vidailhet, M
Bonnet, AM
Descombes, S
Jaillon, C
Agid, Y
Brefel, C
Rascol, O
Xie, J
Pollak, P
Cattelin, F
Citation: I. Arnulf et al., Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease, J NE NE PSY, 70(6), 2001, pp. 812-813
Authors:
Bonnet, AM
Citation: Am. Bonnet, Involvement of non-dopaminergic pathways in Parkinson's disease - Pathophysiology and therapeutic implications, CNS DRUGS, 13(5), 2000, pp. 351-364
Authors:
Arnulf, I
Bejjani, BP
Garma, L
Bonnet, AM
Damier, P
Pidoux, B
Dormont, D
Cornu, P
Derenne, JP
Agid, Y
Citation: I. Arnulf et al., Effect of low and high frequency thalamic stimulation on sleep in patientswith Parkinson's disease and essential tremor, J SLEEP RES, 9(1), 2000, pp. 55-62
Authors:
Bonnet, AM
Semeria, MN
Boronat, JF
Fournier, T
Pontonnier, L
Citation: Am. Bonnet et al., Investigation of the growth mechanisms and electron emission properties ofcarbon nanostructures prepared by hot-filament chemical vapour deposition, DIAM RELAT, 9(3-6), 2000, pp. 852-855
Authors:
Bejjani, BP
Arnulf, I
Vidailhet, M
Pidoux, B
Damier, P
Papadopoulos, S
Bonnet, AM
Cornu, P
Dormont, D
Agid, Y
Citation: Bp. Bejjani et al., Irregular jerky tremor, myoclonus, and thalamus: A study using low-frequency stimulation, MOVEMENT D, 15(5), 2000, pp. 919-924
Authors:
Bejjani, BP
Arnulf, I
Demeret, S
Damier, P
Bonnet, AM
Houeto, JL
Agid, Y
Citation: Bp. Bejjani et al., Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible?, ANN NEUROL, 47(5), 2000, pp. 655-658
Authors:
Yelnik, J
Damier, P
Bejjani, BP
Francois, C
Gervais, D
Dormont, D
Arnulf, I
Bonnet, AM
Cornu, P
Pidoux, B
Agid, Y
Citation: J. Yelnik et al., Functional mapping of the human globus pallidus: Contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease, NEUROSCIENC, 101(1), 2000, pp. 77-87
Authors:
Bonnet, AM
Citation: Am. Bonnet, The Unified Parkinson's Disease Rating Scale (UPDRS), REV NEUROL, 156(5), 2000, pp. 534-541
Authors:
Bonnet, AM
Citation: Am. Bonnet, Rating scales for Parkinson's disease: when and how to use them, REV NEUROL, 156, 2000, pp. 70-75
Authors:
Houeto, JL
Bejjani, PB
Damier, P
Staedler, C
Bonnet, AM
Pidoux, B
Dormont, D
Cornu, P
Agid, Y
Citation: Jl. Houeto et al., Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD, NEUROLOGY, 55(5), 2000, pp. 728-730
Authors:
Pillon, B
Ardouin, C
Damier, P
Krack, P
Houeto, JL
Klinger, H
Bonnet, AM
Pollak, P
Benabid, AL
Agid, Y
Citation: B. Pillon et al., Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease, NEUROLOGY, 55(3), 2000, pp. 411-418
Authors:
Arnulf, I
Bonnet, AM
Damier, P
Bejjani, BP
Seilhean, D
Derenne, JP
Agid, Y
Citation: I. Arnulf et al., Hallucinations, REM sleep, and Parkinson's disease - A medical hypothesis, NEUROLOGY, 55(2), 2000, pp. 281-288
Authors:
Arnulf, I
Bejjani, BP
Garma, L
Bonnet, AM
Houeto, JL
Damier, P
Derenne, JP
Agid, Y
Citation: I. Arnulf et al., Improvement of sleep architecture in PD with subthalamic nucleus stimulation, NEUROLOGY, 55(11), 2000, pp. 1732-1734
Authors:
Bejjani, BP
Dormont, D
Pidoux, B
Yelnik, J
Damier, P
Arnulf, I
Bonnet, AM
Marsault, C
Agid, Y
Philippon, J
Cornu, P
Citation: Bp. Bejjani et al., Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiologicalguidance, J NEUROSURG, 92(4), 2000, pp. 615-625
Authors:
Bejjani, BP
Gervais, D
Arnulf, I
Papadopoulos, S
Demeret, S
Bonnet, AM
Cornu, P
Damier, P
Agid, Y
Citation: Bp. Bejjani et al., Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation, J NE NE PSY, 68(5), 2000, pp. 595-600
Authors:
Tassin, J
Durr, A
Bonnet, AM
Gil, R
Vidailhet, M
Lucking, CB
Goas, JY
Durif, F
Abada, M
Echenne, B
Motte, J
Lagueny, A
Lacomblez, L
Jedynak, P
Bartholome, B
Agid, Y
Brice, A
Citation: J. Tassin et al., Levodopa-responsive dystonia - GTP cyclohydrolase I or parkin mutations?, BRAIN, 123, 2000, pp. 1112-1121
Authors:
Houeto, JL
Damier, P
Bejjani, PB
Staedler, C
Bonnet, AM
Arnulf, I
Pidoux, B
Dormont, D
Cornu, P
Agid, Y
Citation: Jl. Houeto et al., Subthalamic stimulation in Parkinson disease - A multidisciplinary approach, ARCH NEUROL, 57(4), 2000, pp. 461-465
Authors:
Bonnet, AM
Deldem, M
Beaugnon, E
Fournier, T
Schouler, MC
Mermoux, M
Citation: Am. Bonnet et al., Carbon nanostructures and diamond growth by HFCVD: role of the substrate preparation and synthesis conditions, DIAM RELAT, 8(2-5), 1999, pp. 631-635
Authors:
Agid, Y
Destee, A
Durif, F
Montastruc, JL
Pedarriosse, AM
Deptula, D
Hoffman-La Roche, F
Pollak, P
Bonnet, AM
Allain, H
le Cavorzin, P
Barroche, G
Blin, O
Cesaro, P
Chazot, G
Broussolle, E
Leduc, V
Debilly, B
Feve, JR
Geraud, G
Fabre, N
Gu, C
Gil, R
Henry, P
Tison, F
Ansquer, O
Brefel, C
Payen, I
Said, G
Plante, V
Touchon, J
Cesari, JB
Camu, W
Bennys, K
Viallet, F
Warter, JM
Tranchant, C
Ziegler, M
Citation: Y. Agid et al., Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients, MOVEMENT D, 14(1), 1999, pp. 38-44